her2阳性胃癌患者靶向治疗援助项目启动（The target therapy aid project for HER2 positive gastric cancer patients is initiated）.docVIP

her2阳性胃癌患者靶向治疗援助项目启动（The target therapy aid project for HER2 positive gastric cancer patients is initiated） The target therapy aid project for HER2 positive gastric cancer patients is initiated Recently, sponsored by the Herceptin HER2 positive gastric cancer patient assistance project was officially launched by the China cancer foundation, who are HER2 positive gastric cancer patients with certain medical and economic conditions for the. At present, a total of 50 hospitals in 31 cities participated in the aid program. The Hessaitin administration of the project was supported by the Shanghai Roche pharmaceutical Ltd. China Cancer Foundation Deputy Secretary General of the history of Anli long introduction, the aid project plan will be phased promotion to the country in 31, the first in the city, there are nearly 200 medical workers in 50 hospitals of the authorized certification, will provide targeted services for patients, patients can log China Cancer Foundation website related information. Any patient with HER2 positive gastric cancer who meets certain medical and economic conditions may consult with a designated / authorized doctor or a designated pharmacist at a local designated hospital or a designated pharmacy. Medical conditions are checked by designated doctors, and patients with relatively complicated medical conditions are further checked by the project expert group. Approximately 6 of Hessaitins treatment costs will be reduced by approved patients. Tumor Hospital of Peking University vice president Professor Shen Lin pointed out that as long as the HER2 positive patients with gastric cancer, lost the chance of surgical treatment, can benefit from Herceptin treatment, while there is no drug risk patients are consistent with medical requirements of patients, to Chinese Cancer Fund submission. Our country is the first country in the world of gastric cancer, gastric cancer incidence in China in 2013 may reach more than 470 thousand, accounted for 40% of the